Helus Pharma (R7E.MU) Q1 2026 Earnings

16FebConfirmed
Q1 2026
-0.84
-0.77
-0.71
-0.64

Details

Expected EPS
-0.6416378818377
Actual EPS
-0.837509457543
Surprise EPS
-0.2
Surprise Percent
+30.53%

Description

Helus Pharma (R7E.MU) has reported earnings of -0.837509457543 per share for Q1 2026.

0 Comments

Share your thoughts